申请人:Mochida Pharmaceutical Company, Limited
公开号:US05397781A1
公开(公告)日:1995-03-14
The present invention relates to novel 5-(.omega.-substituted amino-alkanoyl amino)pyrimidine derivatives, processes for producing the derivatives, and pharmaceutical compositions containing said derivatives. The compounds in the present invention have potent effects of inhibiting ACAT activity and lowering serum cholesterol. The compounds of the present invention are extremely useful for the treatment and/or prevention of arteriosclerosis or hyperlipidemia.
本发明涉及新型5-(ω-取代氨基-烷酰氨基)嘧啶衍生物,制备这些衍生物的方法,以及含有这些衍生物的药物组合物。本发明中的化合物具有抑制ACAT活性和降低血清胆固醇的强效作用。本发明中的化合物对于治疗和/或预防动脉粥样硬化或高脂血症非常有用。